198 related articles for article (PubMed ID: 28533673)
1. Cost-effectiveness of enhanced liver fibrosis test to assess liver fibrosis in chronic hepatitis C virus and alcoholic liver disease patients.
Soto M; Sampietro-Colom L; Lasalvia L; Mira A; Jiménez W; Navasa M
World J Gastroenterol; 2017 May; 23(17):3163-3173. PubMed ID: 28533673
[TBL] [Abstract][Full Text] [Related]
2. Cost-Effectiveness of Noninvasive Screening for Alcohol-Related Liver Fibrosis.
Asphaug L; Thiele M; Krag A; Melberg HO
Hepatology; 2020 Jun; 71(6):2093-2104. PubMed ID: 31595545
[TBL] [Abstract][Full Text] [Related]
3. Cost-effectiveness of non-invasive methods for assessment and monitoring of liver fibrosis and cirrhosis in patients with chronic liver disease: systematic review and economic evaluation.
Crossan C; Tsochatzis EA; Longworth L; Gurusamy K; Davidson B; Rodríguez-Perálvarez M; Mantzoukis K; O'Brien J; Thalassinos E; Papastergiou V; Burroughs A
Health Technol Assess; 2015 Jan; 19(9):1-409, v-vi. PubMed ID: 25633908
[TBL] [Abstract][Full Text] [Related]
4. Non-invasive diagnostic assessment tools for the detection of liver fibrosis in patients with suspected alcohol-related liver disease: a systematic review and economic evaluation.
Stevenson M; Lloyd-Jones M; Morgan MY; Wong R
Health Technol Assess; 2012; 16(4):1-174. PubMed ID: 22333291
[TBL] [Abstract][Full Text] [Related]
5. Transient Elastography and Controlled Attenuation Parameter for Diagnosing Liver Fibrosis and Steatosis in Ontario: An Economic Analysis.
Thavorn K; Coyle D
Ont Health Technol Assess Ser; 2015; 15(19):1-58. PubMed ID: 26664666
[TBL] [Abstract][Full Text] [Related]
6. Cost-effectiveness of treatment for chronic hepatitis C infection in an evolving patient population.
Salomon JA; Weinstein MC; Hammitt JK; Goldie SJ
JAMA; 2003 Jul; 290(2):228-37. PubMed ID: 12851278
[TBL] [Abstract][Full Text] [Related]
7. Non-invasive algorithm of enhanced liver fibrosis and liver stiffness measurement with transient elastography for advanced liver fibrosis in chronic hepatitis B.
Wong GL; Chan HL; Choi PC; Chan AW; Yu Z; Lai JW; Chan HY; Wong VW
Aliment Pharmacol Ther; 2014 Jan; 39(2):197-208. PubMed ID: 24261924
[TBL] [Abstract][Full Text] [Related]
8. Cost effectiveness of fibrosis assessment prior to treatment for chronic hepatitis C patients.
Liu S; Schwarzinger M; Carrat F; Goldhaber-Fiebert JD
PLoS One; 2011; 6(12):e26783. PubMed ID: 22164204
[TBL] [Abstract][Full Text] [Related]
9. [Evaluation of the costs of transient elastography (FibroScan(®)) in the diagnosis of liver fibrosis in HIV patients with hepatitis C virus].
García-Jurado L; Oyagüez I; Casado MÁ; Tural C; González-García J; Ortega E; Pineda JA
Enferm Infecc Microbiol Clin; 2012 Jun; 30(6):294-9. PubMed ID: 22197275
[TBL] [Abstract][Full Text] [Related]
10. Ultrasound elastography for fibrosis surveillance is cost effective in patients with chronic hepatitis C virus in the UK.
Canavan C; Eisenburg J; Meng L; Corey K; Hur C
Dig Dis Sci; 2013 Sep; 58(9):2691-704. PubMed ID: 23720196
[TBL] [Abstract][Full Text] [Related]
11. Transient elastography as a screening tool for liver fibrosis and cirrhosis in a community-based population aged over 45 years.
Roulot D; Costes JL; Buyck JF; Warzocha U; Gambier N; Czernichow S; Le Clesiau H; Beaugrand M
Gut; 2011 Jul; 60(7):977-84. PubMed ID: 21068129
[TBL] [Abstract][Full Text] [Related]
12. Transient elastography for the diagnosis of liver fibrosis: a systematic review of economic evaluations.
van Katwyk S; Coyle D; Cooper C; Pussegoda K; Cameron C; Skidmore B; Brener S; Moher D; Thavorn K
Liver Int; 2017 Jun; 37(6):851-861. PubMed ID: 27699993
[TBL] [Abstract][Full Text] [Related]
13. Liver stiffness measurement versus liver biopsy to predict survival and decompensations of cirrhosis among HIV/hepatitis C virus-coinfected patients.
Macías J; Camacho A; Von Wichmann MA; López-Cortés LF; Ortega E; Tural C; Ríos MJ; Merino D; Téllez F; Márquez M; Mancebo M; Pineda JA
AIDS; 2013 Oct; 27(16):2541-9. PubMed ID: 23736148
[TBL] [Abstract][Full Text] [Related]
14. Inflammation-adapted liver stiffness values for improved fibrosis staging in patients with hepatitis C virus and alcoholic liver disease.
Mueller S; Englert S; Seitz HK; Badea RI; Erhardt A; Bozaari B; Beaugrand M; Lupșor-Platon M
Liver Int; 2015 Dec; 35(12):2514-21. PubMed ID: 26121926
[TBL] [Abstract][Full Text] [Related]
15. Validation and Refinement of Noninvasive Methods to Assess Hepatic Fibrosis: Magnetic Resonance Elastography Versus Enhanced Liver Fibrosis Index.
Sherman KE; Abdel-Hameed EA; Ehman RL; Rouster SD; Campa A; Martinez SS; Huang Y; Zarini GG; Hernandez J; Teeman C; Tamargo J; Liu Q; Mandler R; Baum MK
Dig Dis Sci; 2020 Apr; 65(4):1252-1257. PubMed ID: 31468264
[TBL] [Abstract][Full Text] [Related]
16. ELF-test less accurately identifies liver cirrhosis diagnosed by liver stiffness measurement in non-Asian women with chronic hepatitis B.
Harkisoen S; Boland GJ; van den Hoek JA; van Erpecum KJ; Hoepelman AI; Arends JE
J Clin Virol; 2014 Dec; 61(4):503-8. PubMed ID: 25467860
[TBL] [Abstract][Full Text] [Related]
17. Relationships between fibrosis amounts assessed by morphometry and liver stiffness measurements in chronic hepatitis or steatohepatitis.
Ziol M; Kettaneh A; Ganne-Carrié N; Barget N; Tengher-Barna I; Beaugrand M
Eur J Gastroenterol Hepatol; 2009 Nov; 21(11):1261-8. PubMed ID: 19478678
[TBL] [Abstract][Full Text] [Related]
18. Liver stiffness and aspartate aminotransferase levels predict the risk for liver fibrosis progression in hepatitis C virus/HIV-coinfected patients.
Gonzalez FA; Van den Eynde E; Perez-Hoyos S; Navarro J; Curran A; Burgos J; Falcó V; Ocaña I; Ribera E; Crespo M
HIV Med; 2015 Apr; 16(4):211-8. PubMed ID: 25234826
[TBL] [Abstract][Full Text] [Related]
19. Cost-effectiveness analysis of therapeutic options for chronic hepatitis C genotype 3 infected patients.
Gimeno-Ballester V; Mar J; O'Leary A; Adams R; San Miguel R
Expert Rev Gastroenterol Hepatol; 2017 Jan; 11(1):85-93. PubMed ID: 27500437
[TBL] [Abstract][Full Text] [Related]
20. Cost-effectiveness of noninvasive liver fibrosis tests for treatment decisions in patients with chronic hepatitis C.
Tsochatzis EA; Crossan C; Longworth L; Gurusamy K; Rodriguez-Peralvarez M; Mantzoukis K; O'Brien J; Thalassinos E; Papastergiou V; Noel-Storr A; Davidson B; Burroughs AK
Hepatology; 2014 Sep; 60(3):832-43. PubMed ID: 25043847
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
